CCND1 and breast cancer: In the second study, Ahlin and coworkers have analyzed immunohistochemical nuclear expression of cyclin D1 in 364 breast cancer patients, showing that cyclin D1 expression over the median in ER+ breast cancers was associated with an increased risk for breast cancer-related death, even when adjusted for tumor size and grade [346].